Skip to main content
Fig. 1 | BMC Musculoskeletal Disorders

Fig. 1

From: Activation of FoxO1/SIRT1/RANKL/OPG pathway may underlie the therapeutic effects of resveratrol on aging-dependent male osteoporosis

Fig. 1

Serum calcium, phosphate and bone specific alkaline phosphatase levels amongst the studies groups. a Serum calcium levels in control (white column), aged (black column) and aged + resveratrol treated (grey column) groups. b Serum phosphate levels in control (white column), aged (black column) and aged + resveratrol treated (grey column) groups. c Serum bone specific alkaline phosphatase levels in control (white column), aged (black column) and aged + resveratrol treated (grey column) groups. (Significant = p < 0.05, * significant when compared to the control group, • significant when compared to the aged group. Number of rats = 10/group)

Back to article page